Influence of recanalization on uric acid patterns in acute ischemic stroke

Cerebrovascular Diseases

Volumn 29, Issue 5, 2010, Pages 431-439

  Hong, Ji Man ^a   Bang, Oh Young ^b   Chung, Chin Sang ^b   Joo, In Soo ^a   Gwag, Byoung Joo ^a   Ovbiagele, Bruce ^c  

^a Ajou University School of Medicine   (South Korea)

^b Sungkyunkwan University   (South Korea)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute ischemic stroke; Antioxidants; Ischemia reperfusion; Neuroprotection; Uric acid

Indexed keywords

ALLANTOIN; URIC ACID;

ACUTE DISEASE; ADULT; AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN ISCHEMIA; CONTROLLED STUDY; DEMOGRAPHY; DIFFUSION WEIGHTED IMAGING; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROGNOSIS; RECANALIZATION; SYMPTOM; URIC ACID BLOOD LEVEL;

AGED; ALLANTOIN; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STROKE; TIME FACTORS; URIC ACID; VASCULAR PATENCY;

EID: 77951875489     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000289346     Document Type: Article

References (37)

1. Fang J, Alderman MH: Serum uric acid and cardiovascular mortality: the NHANES I epidemiologic follow-up study, 1971-1992. National Health and Nutrition Examination Survey. JAMA 2000; 283: 2404-2410.
2. Leyva F, Anker S, Swan JW, Godsland IF, Wingrove CS, Chua TP, et al: Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J 1997; 18: 858-865. (Pubitemid 27208159)
3. Onat A, Uyarel H, Hergenc G, Karabulut A, Albayrak S, Sari I, et al: Serum uric acid is a determinant of metabolic syndrome in a population-based study. Am J Hypertens 2006; 19: 1055-1062. (Pubitemid 44485960)
4. Bos MJ, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM: Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006; 37: 1503-1507. (Pubitemid 44305733)
5. Weir CJ, Muir SW, Walters MR, Lees KR: Serum urate as an independent predictor of poor outcome and future vascular events after acute stroke. Stroke 2003; 34: 1951-1956.
6. Ames BN, Cathcart R, Schwiers E, Hochstein P: Uric acid provides an antioxidant defense in humans against oxidant- and radicalcaused aging and cancer: a hypothesis. Proc Natl Acad Sci USA 1981; 78: 6858-6862. (Pubitemid 12216861)
7. Becker BF: Towards the physiological function of uric acid. Free Radic Biol Med 1993; 14: 615-631.
8. Waring WS: Uric acid: an important antioxidant in acute ischaemic stroke. Q J Med 2002; 95: 691-693. (Pubitemid 35203638)
9. Johnson RJ, Kang DH, Feig D, Kivlighn S, Kanellis J, Watanabe S, et al: Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 2003; 41: 1183-1190. (Pubitemid 36706063)
10. Hink HU, Santanam N, Dikalov S, McCann L, Nguyen AD, Parthasarathy S, et al: Peroxidase properties of extracellular superoxide dismutase: role of uric acid in modulating in vivo activity. Arterioscler Thromb Vasc Biol 2002; 22: 1402-1408.
11. Yu ZF, Bruce-Keller AJ, Goodman Y, Mattson MP: Uric acid protects neurons against excitotoxic and metabolic insults in cell culture, and against focal ischemic brain injury in vivo. J Neurosci Res 1998; 53: 613-625. (Pubitemid 28380802)
12. Romanos E, Planas AM, Amaro S, Chamorro A: Uric acid reduces brain damage and improves the benefits of rt-PA in a rat model of thromboembolic stroke. J Cereb Blood Flow Metab 2007; 27: 14-20. (Pubitemid 46006580)
13. Wu XW, Muzny DM, Lee CC, Caskey CT: Two independent mutational events in the loss of urate oxidase during hominoid evolution. J Mol Evol 1992; 34: 78-84.
14. Hellsten Y, Tullson PC, Richter EA, Bangsbo J: Oxidation of urate in human skeletal muscle during exercise. Free Radic Biol Med 1997; 22: 169-174. (Pubitemid 27110115)
15. Tsahar E, Arad Z, Izhaki I, Guglielmo CG: The relationship between uric acid and its oxidative product allantoin: a potential indicator for the evaluation of oxidative stress in birds. J Comp Physiol B 2006; 176: 653-661. (Pubitemid 44284992)
16. Hicks M, Wong LS, Day RO: Identification of products from oxidation of uric acid induced by hydroxyl radicals. Free Radic Res Commun 1993; 18: 337-351.
17. Fagan SC, Hess DC, Hohnadel EJ, Pollock DM, Ergul A: Targets for vascular protection after acute ischemic stroke. Stroke 2004; 35: 2220-2225. (Pubitemid 39129589)
18. Becker LB: New concepts in reactive oxygen species and cardiovascular reperfusion physiology. Cardiovasc Res 2004; 61: 461-470.
19. Schaller B, Graf R: Cerebral ischemia and reperfusion: the pathophysiologic concept as a basis for clinical therapy. J Cereb Blood Flow Metab 2004; 24: 351-371. (Pubitemid 38452228)
20. Meyer BC, Hemmen TM, Jackson CM, Lyden PD: Modified National Institutes of Health Stroke Scale for use in stroke clinical trials: prospective reliability and validity. Stroke 2002; 33: 1261-1266.
21. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, et al: Classification of subtype of acute ischemic stroke: definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993; 24: 35-41.
22. Benzie IF, Chung W, Tomlinson B: Simultaneous measurement of allantoin and urate in plasma: analytical evaluation and potential clinical application in oxidant-antioxidant balance studies. Clin Chem 1999; 45: 901-904. (Pubitemid 29266623)
23. McCord JM: Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 1985; 312: 159-163. (Pubitemid 15192863)
24. Meneshian A, Bulkley GB: The physiology of endothelial xanthine oxidase: from urate catabolism to reperfusion injury to inflammatory signal transduction. Microcirculation 2002; 9: 161-175. (Pubitemid 135685560)
25. Cherubini A, Polidori MC, Bregnocchi M, Pezzuto S, Cecchetti R, Ingegni T, et al: Antioxidant profile and early outcome in stroke patients. Stroke 2000; 31: 2295-2300.
26. Leinonen JS, Ahonen JP, Lonnrot K, Jehkonen M, Dastidar P, Molnar G, et al: Low plasma antioxidant activity is associated with high lesion volume and neurological impairment in stroke. Stroke 2000; 31: 33-39. (Pubitemid 30035749)
27. Polidori MC, Mecocci P, Frei B: Plasma vitamin C levels are decreased and correlated with brain damage in patients with intracranial hemorrhage or head trauma. Stroke 2001; 32: 898-902. (Pubitemid 32285157)
28. Schretlen DJ, Inscore AB, Vannorsdall TD, Kraut M, Pearlson GD, Gordon B, et al: Serum uric acid and brain ischemia in normal elderly adults. Neurology 2007; 69: 1418-1423. (Pubitemid 47511463)
29. Seet RC, Kasiman K, Gruber J, Tang SY, Wong MC, Chang HM, Chan YH, Halliwell B, Chen CP: Is uric acid protective or deleterious in acute ischemic stroke? A prospective cohort study. Atherosclerosis 2009, E-pub ahead of print.
30. Polidori MC, Frei B, Cherubini A, Nelles G, Rordorf G, Keaney JF Jr, et al: Increased plasma levels of lipid hydroperoxides in patients with ischemic stroke. Free Radic Biol Med 1998; 25: 561-567. (Pubitemid 28390312)
31. Heo JH, Han SW, Lee SK: Free radicals as triggers of brain edema formation after stroke. Free Radic Biol Med 2005; 39: 51-70.
32. Chan PH, Schmidley JW, Fishman RA, Longar SM: Brain injury, edema, and vascular permeability changes induced by oxygen-derived free radicals. Neurology 1984; 34: 315-320.
33. Doehner W, Schoene N, Rauchhaus M, Leyva- Leon F, Pavitt DV, Reaveley DA, et al: Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure: results from 2 placebo-controlled studies. Circulation 2002; 105: 2619-2624. (Pubitemid 34596038)
34. Amaro S, Soy D, Obach V, Cervera A, Planas AM, Chamorro A: A pilot study of dual treatment with recombinant tissue plasminogen activator and uric acid in acute ischemic stroke. Stroke 2007; 38: 2173-2175. (Pubitemid 47012285)
35. Shin DH, Moon GJ, Bang OY: Albumin therapy in acute stroke patients. J Neurol 2007; 254: 870-878. (Pubitemid 47222307)
36. Linfante I, Llinas RH, Schlaug G, Chaves C, Warach S, Caplan LR: Diffusion-weighted imaging and National Institutes of Health Stroke Scale in the acute phase of posteriorcirculation stroke. Arch Neurol 2001; 58: 621-628. (Pubitemid 32295714)
37. TIMI Study Group: The Thrombolysis in Myocardial Infarction (TIMI) trial: phase I findings. N Engl J Med 1985; 312: 932-936. (Pubitemid 15105692)